Gene drive turns mosquitoes into malaria fighters

See allHide authors and affiliations

Science  27 Nov 2015:
Vol. 350, Issue 6264, pp. 1014
DOI: 10.1126/science.350.6264.1014

The blue in these mosquitoes indicates where they express engineered mouse genes that can interfere with malaria parasites.


The war against malaria has a new ally: a controversial technology for spreading genes throughout a population of animals. In the laboratory, researchers have harnessed a so-called gene drive to efficiently endow mosquitoes with genes that make them immune to the malaria parasite—and unable to spread it. On its own, gene drive won't get rid of malaria, but if successfully applied in the wild the method could help wipe out the disease, at least in some corners of the world. The approach “can bring us to zero [cases],” says Nora Besansky, a geneticist at the University of Notre Dame in South Bend, Indiana, who specializes in malaria-carrying mosquitoes.

But testing that promise in the field may have to wait until a wider debate over gene drives is resolved. The essence of this long-discussed strategy for spreading an engineered gene is to bias inheritance so that more than the expected half of a subsequent generation inherits it. Gene drive attracted new attention earlier this year, when geneticists studying fruit flies adapted a gene editing technology called CRISPR-Cas9 to help spread a mutation—and were startled to find it worked so well that the mutation reached almost all fly progeny. Their report, published this spring in Science (20 March, p. 1300), came out less than a year after an eLife paper had warned that a CRISPR-Cas9 gene drive system could disrupt ecosystems and wipe out populations of entire species.

A firestorm quickly erupted over the risks of experimenting with gene drives, nevermind applying them in the field. The U.S. National Academy of Sciences has convened a committee to weigh the risks and propose safeguards, and the authors of the eLife and Science papers have laid out guidelines for experiments (Science, 28 August, p. 927).

Meanwhile, for the past 20 years, Anthony James, a geneticist at the University of California (UC), Irvine, has tried to engineer mosquitoes so they can no longer host the malaria parasite. In 2012, his team pinned down mouse genes for antibodies that make rodents immune to the human malaria pathogen and put them in a mosquito species that spreads malaria in India. The antibodies, as hoped, interrupted the parasite's life cycle within the insect. But James had no way to spread those antibody genes through countless millions of mosquitoes in nature.

Earlier this year James got an email from Ethan Bier, the geneticist at UC San Diego whose lab was doing the soon-to-be-published gene drive research in fruit flies. Bier thought he had a solution to James's dilemma. “As soon as we saw [gene drive] could work, we thought of mosquitoes,” Bier says. James was thrilled, but wondered whether the system could ferry the hefty 17,000 bases of DNA containing the mouse antibody genes. “The question was, ‘Would it carry a large cargo that would remain active?’” James recalls. He and Bier teamed up to see.

Valentino Gantz from Bier's lab and Nijole Jasinskiene, a molecular biologist at UC Irvine, began by engineering male and female Anopheles stephensi to carry the gene drive system. They had designed the system so that, along with spreading the antibody genes from one half of a chromosome pair to the other—the key to biasing inheritance—it would also cut out a piece of a gene responsible for eye color. When they mated the altered mosquitoes with normal ones, they could quickly see whether the gene drive had worked: Offspring that had inherited the anti body genes also had white eyes.

The technology was efficient, endowing about 99% of the transgenic male's offspring with the added genes, Bier and James's teams reported this week in the Proceedings of the National Academy of Sciences. And as hoped, those genes were active in the mosquitoes. Earlier experiments had shown that if the anti body genes were expressed, they thwarted the parasite. “We've got all the pieces,” James says. “It's a question of [making] a product that people will want.”

And that is the big if. James, Bier, and their colleagues adequately addressed concerns about accidental releases of the transgenic mosquitoes, say several outside researchers contacted by Science. The insectaries were behind five sets of doors, and they used a mosquito that doesn't survive in California, should it manage to escape.

But before such work continues, says evolutionary engineer Kevin Esvelt from Harvard University, biologists should look at the ecological effects of gene-driven changes, make sure the changes are stable over many generations, and develop a way to counter or get rid of the gene drive if problems arise.

Because the antiparasite genes should continue to spread ad infinitum among a mosquito population, national and international regulations need to be worked out before gene drives are deployed in the field, adds social scientist Kenneth Oye from the Massachusetts Institute of Technology in Cambridge. “How are we going to decide as a society whether, when, and how to use gene drive to solve a problem?” he asks. Adds Esvelt, who even before there is an appropriate gene drive technology to spread anti–Lyme disease genes in mice is discussing the idea with the public, doctors, and government officials: “At the end of the day, unless you have widespread public support, you can't do it.”

James accepts that his dream may be deferred for now. “If it turns out we are too far ahead of the curve, we'll just have to wait for people to catch up,” he says. “I hope I don't have to wait the rest of my productive career, but if we can't find a way to do it ethically, then it won't be done.”

View Abstract

Navigate This Article